These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23449477)

  • 1. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
    Aliabadi HM; Mahdipoor P; Uludağ H
    Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
    Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
    Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
    Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
    Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H
    J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
    Thapa B; Bahadur Kc R; Uludağ H
    Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
    Cheng D; Cao N; Chen J; Yu X; Shuai X
    Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F
    J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand.
    Oh B; Park S; Pak JH; Kim I
    Biochem Biophys Res Commun; 2012 May; 422(1):42-7. PubMed ID: 22554523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia.
    Jafarlou M; Shanehbandi D; Dehghan P; Mansoori B; Othman F; Baradaran B
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1792-1798. PubMed ID: 29113504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of Mcl-1 gene on ATRA-resistant HL-60 cell].
    Fu JR; Liu WL; Zhou JF; Sun HY; Zheng M; Huang M; Li CR; Ran D; Luo L
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):352-4. PubMed ID: 16185481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.
    Abbasi M; Lavasanifar A; Uludag H
    Med Res Rev; 2013 Jan; 33(1):33-53. PubMed ID: 21523793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells.
    Navarro G; Sawant RR; Biswas S; Essex S; Tros de Ilarduya C; Torchilin VP
    Nanomedicine (Lond); 2012 Jan; 7(1):65-78. PubMed ID: 22191778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.